Guoqing Cao
曹国庆
Guoqing Cao is a pharmaceutical executive and founder currently serving as CEO of Minghui Pharmaceutical, which he established in 2018 to focus on innovative drug R&D . Prior to founding Minghui, he returned to China in 2012 and spent six years as a deputy general manager at Hengrui Medicine . In August 2025, he led Minghui through a $131 million pre-IPO financing round co-led by Qiming Venture Partners and joined by 5Y Capital, among others .
AI-generated — may contain errors, please verify.
Guoqing CaoPerson
曹国庆
渲染中…
Mentioned in 3 articles
Coverage
5Y News｜Minghui Pharma Closes $131 Million Pre-IPO Round to Accelerate Pipeline Development and Global Expansion
Dedicated to developing innovative therapies that address unmet clinical needs worldwide.
Minghui Pharmaceutical Raises $131M in Pre-IPO Round Co-Led by Qiming Venture Partners
Minghui Pharmaceutical is a late-stage biopharmaceutical company focused on oncology and autoimmune diseases.
